CD33- and CD22-targeted ADCs conjugated to calicheamicin, such as GO and InO, are consistently associated with hepatotoxicity and sinusoidal obstruction syndrome [24,109,110]. Here, CD33 is linked to hepatic veno-occlusive disease.